$AZRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AzurRx BioPharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AzurRx BioPharma, Inc.. Get notifications about new insider transactions in AzurRx BioPharma, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | AZRX | AzurRx BioPharma, ... | Oakes Gregory | Option Exercise | A | 0.97 | 41,237 | 40,000 | 41,237 | ||
Jan 06 2021 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Option Exercise | A | 0.97 | 41,237 | 40,000 | 41,237 | ||
Jan 06 2021 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Option Exercise | A | 0.97 | 41,237 | 40,000 | 41,237 | ||
Jan 06 2021 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Option Exercise | A | 0.97 | 41,237 | 40,000 | 41,237 | ||
Jan 06 2021 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.97 | 41,237 | 40,000 | 41,237 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Pennington James | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.85 | 300,000 | 255,000 | 300,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Pennington James | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.75 | 110,000 | 192,500 | 110,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Pennington James | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.85 | 300,000 | 255,000 | 300,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | D | 1.07 | 100,000 | 107,000 | 0 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.85 | 25,774 | 21,908 | 25,774 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Pennington James | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.75 | 110,000 | 192,500 | 110,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.85 | 230,602 | 196,012 | 230,602 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.77 | 46 | 35 | 46 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | D | 1.07 | 100,000 | 107,000 | 0 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.85 | 250,000 | 212,500 | 250,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.85 | 25,774 | 21,908 | 25,774 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.85 | 35,006 | 29,755 | 35,006 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.85 | 230,602 | 196,012 | 230,602 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | J | 1.03 | 35,006 | 36,056 | 300,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.77 | 46 | 35 | 46 | ||
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 64,935 | 55,195 | 64,935 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.85 | 250,000 | 212,500 | 250,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.77 | 13 | 10 | 13 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.85 | 35,006 | 29,755 | 35,006 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 1,200,000 | 1,020,000 | 1,200,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | J | 1.03 | 35,006 | 36,056 | 300,000 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 64,935 | 55,195 | 64,935 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.77 | 13 | 10 | 13 | |
Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 1,200,000 | 1,020,000 | 1,200,000 | |
Apr 16 2020 | AZRX | AzurRx BioPharma, ... | Oakes Gregory | Option Exercise | A | 0.97 | 60,000 | 58,200 | 60,000 | ||
Apr 16 2020 | AZRX | AzurRx BioPharma, ... | Oakes Gregory | Option Exercise | A | 0.97 | 60,000 | 58,200 | 60,000 | ||
Apr 07 2020 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 | ||
Apr 07 2020 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 | ||
Apr 07 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 | ||
Apr 07 2020 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 | ||
Apr 07 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 | ||
Mar 23 2020 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Gift | G | 0.00 | 9,000 | 0 | 116,998 | 108 K to 117 K (+8.33 %) | |
Mar 23 2020 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Gift | G | 0.00 | 9,000 | 0 | 107,998 | 117 K to 108 K (-7.69 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 1.04 | 8,414 | 8,751 | 132,049 | 123.6 K to 132 K (+6.81 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 0.60 | 14,584 | 8,750 | 123,635 | 109.1 K to 123.6 K (+13.37 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 3.63 | 2,755 | 10,001 | 106,296 | 103.5 K to 106.3 K (+2.66 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 3.99 | 2,507 | 10,003 | 103,541 | 101 K to 103.5 K (+2.48 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 4.74 | 264 | 1,251 | 101,034 | 100.8 K to 101 K (+0.26 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 4.74 | 770 | 3,650 | 100,770 | 100 K to 100.8 K (+0.77 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 1.04 | 8,414 | 8,751 | 116,998 | 108.6 K to 117 K (+7.75 %) | |
Mar 13 2020 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 0.60 | 14,584 | 8,750 | 108,584 | 94 K to 108.6 K (+15.51 %) | |
Jan 09 2020 | AZRX | AzurRx BioPharma, ... | Schneiderman Daniel H | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.03 | 335,006 | 345,056 | 335,006 | |
Jan 03 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 1.07 | 51,547 | 55,155 | 103,094 | ||
Jan 03 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 1.04 | 7,500 | 7,800 | 379,126 | 371.6 K to 379.1 K (+2.02 %) | |
Jan 03 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 1.07 | 51,547 | 55,155 | 103,094 | ||
Jan 03 2020 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 1.04 | 7,500 | 7,800 | 379,126 | 371.6 K to 379.1 K (+2.02 %) | |
Oct 10 2019 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.52 | 300,000 | 156,000 | 300,000 | |
Oct 10 2019 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Oct 01 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 0.60 | 7,500 | 4,500 | 92,500 | 85 K to 92.5 K (+8.82 %) | |
Oct 01 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 0.60 | 7,500 | 4,500 | 86,500 | 79 K to 86.5 K (+9.49 %) | |
Oct 01 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 0.60 | 7,500 | 4,500 | 60,000 | 52.5 K to 60 K (+14.29 %) | |
Oct 01 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 0.60 | 7,500 | 4,500 | 371,626 | 364.1 K to 371.6 K (+2.06 %) | |
Jul 02 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 1.70 | 7,500 | 12,750 | 364,126 | 356.6 K to 364.1 K (+2.10 %) | |
Jul 02 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 1.70 | 7,500 | 12,750 | 85,000 | 77.5 K to 85 K (+9.68 %) | |
Jul 02 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 1.70 | 7,500 | 12,750 | 79,000 | 71.5 K to 79 K (+10.49 %) | |
Jul 02 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 1.70 | 7,500 | 12,750 | 52,500 | 45 K to 52.5 K (+16.67 %) | |
Jun 17 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 0.00 | 30,000 | 0 | 107,500 | 77.5 K to 107.5 K (+38.71 %) | |
Jun 17 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 0.00 | 30,000 | 0 | 101,500 | 71.5 K to 101.5 K (+41.96 %) | |
Jun 17 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 0.00 | 30,000 | 0 | 386,626 | 356.6 K to 386.6 K (+8.41 %) | |
Jun 17 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 0.00 | 30,000 | 0 | 75,000 | 45 K to 75 K (+66.67 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 2.42 | 7,500 | 18,150 | 356,626 | 349.1 K to 356.6 K (+2.15 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 2.42 | 7,500 | 18,150 | 356,626 | 349.1 K to 356.6 K (+2.15 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 2.42 | 7,500 | 18,150 | 71,500 | 64 K to 71.5 K (+11.72 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 2.42 | 7,500 | 18,150 | 71,500 | 64 K to 71.5 K (+11.72 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 2.42 | 7,500 | 18,150 | 77,500 | 70 K to 77.5 K (+10.71 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 2.42 | 7,500 | 18,150 | 77,500 | 70 K to 77.5 K (+10.71 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 2.42 | 7,500 | 18,150 | 45,000 | 37.5 K to 45 K (+20.00 %) | |
Apr 29 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 2.42 | 7,500 | 18,150 | 45,000 | 37.5 K to 45 K (+20.00 %) | |
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 1.50 | 21,429 | 32,144 | 21,429 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | H | 5.50 | 21,429 | 117,860 | 0 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 1.50 | 100,000 | 150,000 | 75,000 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | H | 5.50 | 100,000 | 550,000 | 0 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 1.50 | 371,143 | 556,715 | 371,143 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | H | 5.50 | 371,143 | 2,041,287 | 0 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 1.50 | 273,598 | 410,397 | 273,598 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | H | 5.58 | 273,598 | 1,526,677 | 0 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 2.50 | 1,000,000 | 2,500,000 | 1,000,000 | ||
Feb 19 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 2.50 | 1,000,000 | 2,500,000 | 1,000,000 | ||
Jan 07 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 1.12 | 23,848 | 26,710 | 2,540,555 | 2.5 M to 2.5 M (+0.95 %) | |
Jan 07 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 1.18 | 29,575 | 34,899 | 2,516,707 | 2.5 M to 2.5 M (+1.19 %) | |
Jan 07 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 1.13 | 23,200 | 26,216 | 2,487,132 | 2.5 M to 2.5 M (+0.94 %) | |
Jan 07 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 1.18 | 42,922 | 50,648 | 2,463,932 | 2.4 M to 2.5 M (+1.77 %) | |
Jan 07 2019 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 2.50 | 20,000 | 50,000 | 2,421,010 | 2.4 M to 2.4 M (+0.83 %) | |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Buy | P | 1.30 | 38,583 | 49,969 | 338,617 | 300 K to 338.6 K (+12.86 %) |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Buy | P | 1.31 | 20,000 | 26,214 | 62,500 | 42.5 K to 62.5 K (+47.06 %) |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 1.29 | 7,500 | 9,675 | 349,126 | 341.6 K to 349.1 K (+2.20 %) | |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 1.29 | 7,500 | 9,675 | 37,500 | 30 K to 37.5 K (+25.00 %) | |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 1.29 | 7,500 | 9,675 | 64,000 | 56.5 K to 64 K (+13.27 %) | |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Buy | P | 1.41 | 9,000 | 12,690 | 56,500 | 47.5 K to 56.5 K (+18.95 %) | |
Jan 02 2019 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 1.29 | 7,500 | 9,675 | 70,000 | 62.5 K to 70 K (+12.00 %) | |
Oct 01 2018 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 2.57 | 7,500 | 19,275 | 62,500 | 55 K to 62.5 K (+13.64 %) | |
Oct 01 2018 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 2.57 | 7,500 | 19,275 | 47,500 | 40 K to 47.5 K (+18.75 %) | |
Oct 01 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 2.57 | 7,500 | 19,275 | 341,626 | 334.1 K to 341.6 K (+2.24 %) | |
Oct 01 2018 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 2.57 | 7,500 | 19,275 | 30,000 | 22.5 K to 30 K (+33.33 %) | |
Jul 26 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 0.00 | 7,500 | 0 | 334,126 | 326.6 K to 334.1 K (+2.30 %) | |
Jul 19 2018 | AZRX | AzurRx BioPharma, ... | Pennington James | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.04 | 75,000 | 228,000 | 75,000 | |
Jul 18 2018 | AZRX | AzurRx BioPharma, ... | Dupret Daniel | CHIEF SCIENTIFIC OF ... | Option Exercise | A | 3.04 | 60,000 | 182,400 | 60,000 | |
Jul 18 2018 | AZRX | AzurRx BioPharma, ... | Dupret Daniel | CHIEF SCIENTIFIC OF ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 0.00 | 7,500 | 0 | 55,000 | 47.5 K to 55 K (+15.79 %) | |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 0.00 | 7,500 | 0 | 40,000 | 32.5 K to 40 K (+23.08 %) | |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.04 | 100,000 | 304,000 | 100,000 | |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 0.00 | 7,500 | 0 | 22,500 | 15 K to 22.5 K (+50.00 %) | |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Grant | A | 0.00 | 200,000 | 0 | 300,034 | 100 K to 300 K (+199.93 %) |
Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Grant | A | 0.00 | 200,000 | 0 | 300,034 | 100 K to 300 K (+199.93 %) |
Apr 02 2018 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 3.14 | 7,500 | 23,550 | 32,500 | 25 K to 32.5 K (+30.00 %) | |
Apr 02 2018 | AZRX | AzurRx BioPharma, ... | Schramm Vern Lee | Grant | A | 3.14 | 7,500 | 23,550 | 15,000 | 7.5 K to 15 K (+100.00 %) | |
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | M | 2.50 | 8,640 | 21,600 | 28,474 | ||
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | M | 2.50 | 13,680 | 34,200 | 0 | ||
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | M | 2.50 | 13,680 | 34,200 | 0 | ||
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Buy | M | 2.50 | 13,680 | 34,200 | 13,680 | 0 to 13.7 K | |
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Buy | M | 2.50 | 13,680 | 34,200 | 297,946 | 284.3 K to 297.9 K (+4.81 %) | |
Jan 16 2018 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Buy | M | 2.50 | 8,640 | 21,600 | 284,266 | 275.6 K to 284.3 K (+3.13 %) | |
Nov 14 2017 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Option Exercise | X | 1.00 | 100,000 | 100,000 | 200,000 | |
Nov 14 2017 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Buy | X | 1.00 | 100,000 | 100,000 | 100,034 | 34 to 100 K (+294,117.65 %) |
Nov 01 2017 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Grant | A | 0.00 | 22,500 | 0 | 275,626 | 253.1 K to 275.6 K (+8.89 %) | |
Oct 23 2017 | AZRX | AzurRx BioPharma, ... | Riddell Alastair | Grant | A | 0.00 | 22,500 | 0 | 32,500 | 10 K to 32.5 K (+225.00 %) | |
Oct 23 2017 | AZRX | AzurRx BioPharma, ... | CASAMENTO CHARLES J | Grant | A | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K | |
Oct 23 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 22,500 | 0 | 42,500 | 20 K to 42.5 K (+112.50 %) |
Sep 27 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Option Exercise | A | 4.39 | 100,000 | 439,000 | 100,000 | |
Jul 03 2017 | AZRX | AzurRx BioPharma, ... | Pelican Partners LLC | Sell | S | 3.50 | 60,000 | 210,000 | 1,727,796 | 1.8 M to 1.7 M (-3.36 %) | |
Jul 03 2017 | AZRX | AzurRx BioPharma, ... | Pelican Partners LLC | Sell | S | 3.00 | 100,000 | 300,000 | 1,787,796 | 1.9 M to 1.8 M (-5.30 %) | |
Jun 09 2017 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 5.50 | 128,572 | 707,146 | 96,429 | ||
Jun 09 2017 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | P | 4.00 | 128,572 | 514,288 | 32,143 | ||
Jun 09 2017 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | P | 3.50 | 128,572 | 450,002 | 1,659,840 | 1.5 M to 1.7 M (+8.40 %) | |
Feb 07 2017 | AZRX | AzurRx BioPharma, ... | BORKOWSKI EDWARD | Option Exercise | A | 4.48 | 30,000 | 134,400 | 30,000 | ||
Feb 07 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | Option Exercise | A | 4.48 | 30,000 | 134,400 | 30,000 | ||
Feb 07 2017 | AZRX | AzurRx BioPharma, ... | Spoor Johan M. | PRESIDENT AND CEO | Option Exercise | A | 4.48 | 100,000 | 448,000 | 100,000 | |
Oct 18 2016 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Option Exercise | J | 5.50 | 371,142 | 2,041,281 | 371,142 | ||
Oct 18 2016 | AZRX | AzurRx BioPharma, ... | Ross Edmund Burke Jr. | Buy | C | 4.65 | 1,031,268 | 4,795,396 | 1,531,268 | 500 K to 1.5 M (+206.25 %) | |
Oct 14 2016 | AZRX | AzurRx BioPharma, ... | Pelican Partners LLC | Gift | G | 0.00 | 15,350 | 0 | 1,787,796 | 1.8 M to 1.8 M (-0.85 %) |
Page: 1